Related Experiment Video
Updated: May 22, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000-2009
Rishi Desai1, Aaron T Curns, Claudia A Steiner
1Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. rdesai1@cdc.gov
Insights
The rotavirus vaccine significantly reduced hospitalizations for diarrhea and rotavirus in US children under 5. This vaccination program also led to substantial cost savings in hospital treatment.
Area of Science:
- Pediatric infectious diseases
- Vaccinology
- Public health surveillance
Background:
- Rotavirus vaccine introduction in the US in 2006.
- Need to estimate pre-vaccine burden and post-vaccine trends.
- Focus on gastroenteritis and rotavirus hospitalizations in children.
Purpose of the Study:
- Estimate the prevaccine burden of rotavirus disease.
- Monitor post-vaccine trends in hospitalizations.
- Assess the impact of the rotavirus vaccination program on hospitalization rates and costs.
Main Methods:
- Analysis of State Inpatient Databases (SID) from 29-44 US states (2000-2009).
- Calculation of hospitalization rates for gastroenteritis and rotavirus by age, sex, and region.
- Extrapolation of rates to estimate national reductions in hospitalizations and costs.
Main Results:
- Significant decline in gastroenteritis-coded hospitalizations (74 to 50 per 10,000) and rotavirus-coded hospitalizations (15 to 6 per 10,000) among children <5 years.
- Decreases observed across all age groups and US regions post-vaccination.
- Estimated reduction of ~77,000 diarrhea hospitalizations and ~$242 million in costs in 2008-2009.
Conclusions:
- The US rotavirus vaccination program has led to a significant reduction in diarrhea hospitalizations.
- Marked decrease in related hospital charges among US children.
- Demonstrates the public health and economic benefits of rotavirus vaccination.
Background:
Rotavirus vaccine was recommended for US infants in 2006. We estimated baseline prevaccine burden and monitored postvaccine trends in gastroenteritis-coded and rotavirus-coded hospitalizations among US children.
Methods:
We analyzed data from the State Inpatient Databases (SID) for 29-44 US states over a 10-year period (2000-2009) to calculate gastroenteritis and rotavirus-coded hospitalization rates by age group, sex, and region, among children <5 years of age. By extrapolating observed pre- and postvaccine gastroenteritis hospitalization rates to the US population <5 years and based on the 2009 cost of a diarrhea hospitalization, we estimated national reductions in diarrhea hospitalizations and associated treatment costs.
Results:
The prevaccine (2000-2006) annual average gastroenteritis-coded hospitalization rate among children <5 years of age was 74 per 10,000 (annual range, 71-82 per 10,000), and declined to 51 and 50 per 10,000 in 2008 and 2009, respectively (P < .001). The prevaccine (2000-2006) annual average rotavirus-coded hospitalization rate among children <5 years of age was 15 per 10,000 (annual range, 13-18 per 10,000), and declined to 5 and 6 per 10,000 in 2008 and 2009, respectively (P < .001). The decreases in rotavirus-coded hospitalization rates in 2008 and 2009 compared with rates in prevaccine years were observed among all age groups and US regions. Nationally, during 2008 and 2009 combined, we estimated a reduction of approximately 77,000 diarrhea hospitalizations and approximately $242 million in hospital costs.
Conclusions:
Since implementation of the US rotavirus vaccination program, a marked reduction in diarrhea hospitalizations and related hospital charges has occurred among US children.
Related Concept Videos
Bacterial Gastroenteritis
Investigation of Disease Outbreaks
Cholera
Reservoir of Infection
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...

